Home › Funds › MPM BioImpact LLC › ANNX
MPM BioImpact LLC position in ANNX
ANNEXON INC · Health Care
MPM BioImpact LLC reported holding 3,544,354 shares of ANNX (ANNEXON INC) in its Q2 2026 13F filing — a position valued at US$20.2M, representing 1.23% of its reported portfolio and ranking #32 among its reported holdings. MPM BioImpact LLC first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How MPM BioImpact LLC's ANNX position evolved
MPM BioImpact LLC first disclosed a stake in ANNX in Q2 2026 at 3,544,354 shares (US$20.2M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 3.54M | $20.24M | New |
About ANNX and 13F data
ANNX (ANNEXON INC) is a Health Care company. 45 other funds we track also report a position in ANNX — the largest reported positions include Redmile Group, LLC (US$67.8M), BVF INC/IL (US$49.7M), MAK CAPITAL ONE LLC (US$33.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ANNX
- Redmile Group, LLC 11.87M sh · $67.78M · Q2 2026
- BVF INC/IL 8.70M sh · $49.67M · Q2 2026
- MAK CAPITAL ONE LLC 5.86M sh · $33.47M · Q2 2026
- Siren, L.L.C. 4.46M sh · $25.46M · Q2 2026
- Bain Capital Life Sciences Investors, LLC 4.44M sh · $25.34M · Q2 2026
- Bellevue Group AG 4.10M sh · $23.41M · Q2 2026
- GREAT POINT PARTNERS LLC 3.50M sh · $19.98M · Q2 2026
- Palo Alto Investors LP 2.95M sh · $16.83M · Q2 2026
- Opaleye Management Inc. 1.71M sh · $9.79M · Q2 2026
- Logos Global Management LP 1.50M sh · $8.56M · Q2 2026
- Tetragon Partners GP Ltd 1.24M sh · $7.09M · Q2 2026
- Ishara Investments LP 820.00K sh · $4.68M · Q2 2026
More on MPM BioImpact LLC
FAQ
How long has MPM BioImpact LLC held ANNX?
MPM BioImpact LLC has disclosed ANNX holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is MPM BioImpact LLC's current position in ANNX?
As of Q2 2026, MPM BioImpact LLC holds 3.54M shares of ANNX (ANNEXON INC), valued at $20.24M, representing 1.23% of its reported portfolio and ranking #32.
Has MPM BioImpact LLC been buying or selling ANNX?
In the latest 13F filing (Q2 2026), MPM BioImpact LLC newly opened its position in ANNX.
Which other funds hold ANNX?
Other major institutional holders of ANNX include Redmile Group, LLC, BVF INC/IL, MAK CAPITAL ONE LLC, among 45 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.